National Historical Balance Sheet
NHI Stock | USD 76.91 0.58 0.75% |
Trend analysis of National Health Investors balance sheet accounts such as Property Plant And Equipment Net of 2.2 B provides information on National Health's total assets, liabilities, and equity, which is the actual value of National Health Investors to its prevalent stockholders. By breaking down trends over time using National Health balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining National Health Investors latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether National Health Investors is a good buy for the upcoming year.
National Health Inventory |
|
National |
About National Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of National Health Investors at a specified time, usually calculated after every quarter, six months, or one year. National Health Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of National Health and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which National currently owns. An asset can also be divided into two categories, current and non-current.
National Health Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of National Health assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in National Health Investors books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most accounts from National Health's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into National Health Investors current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, National Health's Other Assets are increasing as compared to previous years. The National Health's current Other Current Liabilities is estimated to increase to about 34.7 M, while Total Assets are projected to decrease to under 1.3 B.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 1.3B | 1.6B | 1.1B | 618.4M | Total Assets | 2.8B | 2.5B | 2.5B | 1.3B |
National Health balance sheet Correlations
Click cells to compare fundamentals
National Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
National Health balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 3.0B | 3.1B | 2.8B | 2.5B | 2.5B | 1.3B | |
Short Long Term Debt Total | 1.5B | 2.0B | 1.3B | 1.6B | 1.1B | 618.4M | |
Total Stockholder Equity | 1.5B | 1.5B | 1.5B | 1.3B | 1.3B | 729.6M | |
Net Debt | 1.4B | 1.5B | 1.2B | 1.1B | 1.1B | 1.2B | |
Retained Earnings | (5.3M) | (22.0M) | (84.6M) | (329.6M) | 2.5B | 2.6B | |
Non Currrent Assets Other | (308K) | 6.8M | 7.5M | 965K | 8.4M | 8.0M | |
Other Assets | 304.3M | 2.8B | 2.5B | 45.5M | 2.1B | 2.2B | |
Common Stock Shares Outstanding | 43.7M | 44.7M | 45.7M | 44.8M | 43.4M | 32.0M | |
Liabilities And Stockholders Equity | 3.0B | 3.1B | 2.8B | 2.5B | 2.5B | 1.3B | |
Non Current Liabilities Total | 1.5B | 1.5B | 1.3B | 1.1B | 1.1B | 559.3M | |
Other Stockholder Equity | 1.5B | 1.6B | 1.6B | 1.6B | (863.1M) | (819.9M) | |
Total Liab | 1.5B | 1.6B | 1.3B | 1.2B | 1.2B | 610.1M | |
Non Current Assets Total | 2.6B | 2.7B | 2.3B | 2.1B | 2.1B | 1.2B | |
Net Receivables | 429.4M | 390.7M | 399.4M | 315.0M | 330.0M | 238.6M | |
Total Current Assets | 463.5M | 437.1M | 505.2M | 379.8M | 352.3M | 256.7M | |
Other Current Liab | 45.6M | (408.6M) | (34.1M) | (376.4M) | 33.1M | 34.7M | |
Total Current Liabilities | 92.9M | 87.6M | 70.2M | 70.0M | 148.8M | 156.2M | |
Accounts Payable | 26.3M | 25.2M | 23.2M | 25.9M | 34.3M | 36.0M | |
Cash | 5.2M | 43.3M | 37.4M | 19.3M | 22.3M | 34.0M | |
Cash And Short Term Investments | 5.2M | 43.3M | 37.4M | 19.3M | 22.3M | 21.2M | |
Common Stock Total Equity | 446K | 452K | 459K | 434K | 499.1K | 351.3K | |
Accumulated Other Comprehensive Income | (3.4M) | (7.1M) | (84.6M) | (329.6M) | (350.2M) | (332.7M) | |
Common Stock | 446K | 452K | 459K | 434K | 499.1K | 355.8K | |
Short Term Debt | 1.2M | 458.4M | 75.4M | 415.4M | 75.4M | 63.4M | |
Other Liab | 30.4M | 23.3M | 14.6M | 5.1M | 4.5M | 4.3M | |
Long Term Debt | 1.4B | 1.5B | 1.2B | 1.1B | 1.1B | 663.6M | |
Current Deferred Revenue | 19.8M | 12.6M | 5.7M | 5.1M | 6.0M | 4.6M | |
Other Current Assets | (431.4M) | (431.5M) | (433.6M) | 45.5M | 7.3M | 7.6M | |
Net Tangible Assets | 1.5B | 1.5B | 1.5B | 1.3B | 1.5B | 1.2B | |
Capital Surpluse | 1.5B | 1.5B | 1.6B | 1.6B | 1.8B | 1.2B | |
Deferred Long Term Liab | 10.1M | 12.6M | 5.7M | 5.1M | 5.8M | 4.6M | |
Long Term Investments | 141.5M | 246.1M | 292.4M | 300.0M | 344.9M | 187.0M |
Currently Active Assets on Macroaxis
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 2.91 | Revenue Per Share 7.598 | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.